CIPLA LTD. (INDIA)

Daunorubicin-daunotec

"Daunorubicin" is the Drug / Molecule content in "Daunotec". Daunotec is an anthracycline, forms a stable complex with DNA and interferes with the nucleic acid synthesis. It also has immunosuppressant and antibacterial effects.

Details
Specification

Indication

Daunorubicin is most commonly used to treat specific types of leukaemia (acute myeloid leukemia and acute lymphocytic leukemia)

Note

Precaution

Daunotec is a prescription drug and should be used under proper medical guidance and advice.
Contraindicated during pregnancy and lactation.

Updated On Oct 25, 2019 by Admin

Strength

20 mg

Packing

Vial

Storage

Store below 25 °C. Reconstituted solution for injection is stable for 24 hr. at room Temperature and 48 hr. under refrigeration (2-8°C) and should be protected from light.